Bill Loo MD PhD ⚡️☢️ (@bloo_lt_sabr) 's Twitter Profile
Bill Loo MD PhD ⚡️☢️

@bloo_lt_sabr

#PhysicianScientist Professor @StanfordRadOnc, #LungCancer Doc, #SABRist, Bioengineer, #PHASER Inventor,⚡️ #FLASH_RT #RadBio, SciFi Nerd, Hubby & Dad of 3 ✝️🇺🇸

ID: 1118332660550520837

linkhttp://profiles.stanford.edu/Billy_Loo calendar_today17-04-2019 01:57:38

575 Tweet

1,1K Takipçi

273 Takip Edilen

Leo Cancer Care (@leo_cancer_care) 's Twitter Profile Photo

🚨 New Collaboration Alert 🚨 We've teamed up with TibaRay to co-develop an upright linear accelerator for photon therapy! Read the press release: obi41.nl/4mpeeuyr #Partnership #Radiotherapy #Innovation  #Partnership #Radiotherapy #Innovation

Hyunsoo Joshua No, MD, CMD (@doctornomd) 's Twitter Profile Photo

Incredible work led by James WS Jahng, PhD exploring ionizing radiation impacts on the cardiovascular system, drawing from nuclear accidents, occupational exposure, and cancer therapy. Providing insights to enhance personalized risk assessments and management strategies to mitigate long

FLASH Radiotherapy & Particle Therapy (@flashrpt) 's Twitter Profile Photo

At #FRPT2024, Vincent Favaudon will present his Life-Time Achievement session and will be honored with an award for his groundbreaking contributions to FLASH radiotherapy. Don't miss and register now: bit.ly/3Wt71vq #FLASHRadiotherapy #Radiotherapy #Radonc

Leo Cancer Care (@leo_cancer_care) 's Twitter Profile Photo

🎉 What a moment! 🎉 Seeing our system craned over trees and into the Stanford Radiation Oncology Clinic was truly remarkable! This isn’t just any installation—it’s the world’s first Mevion S250-FIT system, transforming an existing LINAC vault. #milestone #uprightpioneers

🎉 What a moment! 🎉 Seeing our system craned over trees and into the Stanford Radiation Oncology Clinic was truly remarkable! This isn’t just any installation—it’s the world’s first Mevion S250-FIT system, transforming an existing LINAC vault.

#milestone #uprightpioneers
Mevion Medical (@mevionmedical) 's Twitter Profile Photo

Mevion has successfully delivered the first MEVION S250-FIT Proton Therapy System*. Read the press release now: hubs.la/Q033p-0T0 *The MEVION S250-FIT Proton Therapy System is not yet available for clinical use. #ProtonTherapy #AccessibleCancerCare

Nikhil Kotha, MD (@nikhilvkotha) 's Twitter Profile Photo

🙏🏽 huge thanks to the patients and team and mentors (highlighted by Michael Gensheimer and Bill Loo MD PhD ⚡️☢️)! Presenting it as an ASTRO oral was icing on the cake, excited to see how synergistic therapies in this realm continue to evolve! 🙌🏽

Stanford Radiation Oncology (@stanfordradonc) 's Twitter Profile Photo

Please join us in congratulating Quynh Thu Le, our department chair, as a 2025 ASTRO Gold Medal Recipient! The Gold Medal is ASTRO's highest honor bestowed on revered members who have made outstanding contributions to radiation oncology. Congratulations, Quynh! #ASTRO2025

Please join us in congratulating <a href="/Qle_stanford/">Quynh Thu Le</a>, our department chair, as a 2025 <a href="/ASTRO_org/">ASTRO</a> Gold Medal Recipient! The Gold Medal is ASTRO's highest honor bestowed on revered members who have made outstanding contributions to radiation oncology. Congratulations, Quynh! #ASTRO2025
Lei Xing (@lx2015) 's Twitter Profile Photo

A symposium focusing on AI foundation models, generative models, and agentic AI will be held on Stanford campus before ASTRO annual meeting in SF. Please mark your calendars; detailed program and registration website for the symposium will be made available online soon.

A symposium focusing on AI foundation models, generative models, and agentic AI will be held on Stanford campus before ASTRO annual meeting in SF.  Please mark your calendars; detailed program and registration website for the symposium will be made available online soon.
Joe Y Chang (@joechangmd) 's Twitter Profile Photo

First phase III randomized study showed an improvement in overall survival with proton-based IMPT compared to photon IMRT in head and neck cancer. This was presented today during the The Particle Therapy Co-Operative Group (PTCOG) plenary session by Steven J. Frank, MD. The exciting data provides justification for IMPT.

First phase III randomized study showed an improvement in overall survival with proton-based IMPT compared to photon IMRT in head and neck cancer. This was presented today during the <a href="/PTCOG_Official/">The Particle Therapy Co-Operative Group (PTCOG)</a> plenary session by <a href="/SJFrankMD/">Steven J. Frank, MD</a>. The exciting data provides justification for IMPT.
Stanford Radiation Oncology (@stanfordradonc) 's Twitter Profile Photo

A special shoutout to our keynote speaker, Minsong Cao, for delivering an inspiring talk! Congratulations to all the winners: 🏆 Renesmee Kuo, Dixin Chen, Yibing Zhang, Veng Jean Heng & Zhuoran Jiang, Theodore Geoghegan, Vivek Maradia & Xiaoxu Zhong, Brendan Floyd.